Incor Heart Institute
Clinical trials sponsored by Incor Heart Institute, explained in plain language.
-
Dietary change cuts diabetes damage markers by 30%
Disease control CompletedThis study tested a diet low in advanced glycation end products (AGEs) in 36 adults aged 55-65 with type 2 diabetes and coronary artery disease. After reducing AGE intake by 56%, participants saw a 30% drop in a blood marker linked to diabetes complications. The diet also increas…
Phase: NA • Sponsor: InCor Heart Institute • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Heart health mystery: do statins and quercetin change estrogen in older women?
Knowledge-focused CompletedThis study looked at 60 postmenopausal women with stable coronary artery disease to see how the statin atorvastatin and the natural compound quercetin affect estrogen levels and a protein called SIRT1. The goal was to understand possible links between these treatments and hormone…
Phase: NA • Sponsor: InCor Heart Institute • Aim: Knowledge-focused
Last updated May 02, 2026 18:15 UTC